INVITRO ACTIVITY AND HUMAN PHARMACOKINETICS OF TEICOPLANIN
INVITRO ACTIVITY AND HUMAN PHARMACOKINETICS OF TEICOPLANIN
复制标题
DOI:
10.1128/aac.26.6.881
复制
发表时间:
1984-01-01
影响因子:
4.9
通讯作者:
DESCHEPPER, PJ
中科院分区:
文献类型:
--
作者:
VERBIST, L;TJANDRAMAGA, B;DESCHEPPER, PJ
The in vitro activity of teicoplanin, a new antibiotic related to vancomycin, was determined against 456 gram-positive cocci. The activity of teicoplanin in comparison with that of vancomycin was similar against staphylococci, but 4-40 times higher against enterococci and .beta.-hemolytic and viridans streptococci. The single-dose pharmacokinetics of teicoplanin were studied in 6 healthy volunteers after administration of 3 and 6 mg/kg i.v. and of 3 mg/kg i.m. The kinetic parameters after both i.v. doses were very similar. The curves for concentration in plasma for the 3- and 6-mg/kg intravenous doses showed a triexponential decline with elimination half-lives of 47.3 and 44.1 h, respectively. The percentages of the doses recovered in urine (0-102 h) were 43.2 and 44.1%, respectively. The areas under the plasma curves were dose related: 256.5 and 520.9 .mu.g/h per ml, respectively. The bioavailability of teicoplanin after injection of 3 mg/kg i.m. was 90% and the peak level was 7.1 .mu.g/ml. The mean levels in plasma 24 h after the 3-mg/kg doses were 2.1 and 2.3 .mu.g/ml, respectively, and the mean level in plasma 24 h after the 6-mg/kg i.v. dose was 4.2 .mu.g/ml.